Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|July 6, 2024
Establishment and characterization of cMYB-expressing human salivary adenoid cystic carcinoma cell lines (UM-HACC-14, UM-HACC-6) and matching patient-derived xenograft model (UM-PDX-HACC-14)Kristy A Warner, Alexandra E Herzog, Sosuke Sahara, et al.
Oral Oncology|December 12, 2018
UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell lineKristy A Warner, Alexandra E Oklejas, Alexander T Pearson, et al.
Cell Death & Disease|October 24, 2021
The IL-6R and Bmi-1 axis controls self-renewal and chemoresistance of head and neck cancer stem cellsAlexandra E Herzog, Kristy A Warner, Zhaocheng Zhang, et al.
Cancer Research|June 17, 2005
Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokinesElisabeta Karl, Kristy Warner, Benjamin Zeitlin, et al.
Translational Oncology|November 25, 2025
Bmi-1 inhibition sensitizes head and neck cancer stem cells to cytotoxic chemotherapyAlexandra E Herzog, Shirley Zheng, Kristy A Warner, et al.
Molecular Cancer Therapeutics|February 27, 2014
The G protein-coupled receptor GALR2 promotes angiogenesis in head and neck cancerRajat Banerjee, Elizabeth A Van Tubergen, Christina S Scanlon, et al.
Stem Cells (Dayton, Ohio)|August 1, 2014
Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cellsSudha Krishnamurthy, Kristy A Warner, Zhihong Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite VaccineYee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
SOX2-induced IL1α-mediated immune suppression drives epithelial dysplasia malignant transformationHülya F Taner, Wang Gong, Zackary R Fitzsimonds, et al.
The Journal of Clinical Investigation|December 25, 2019
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STINGXiaobo Luo, Christopher R Donnelly, Wang Gong, et al.
Pageof 5